While the first few months of the year witnessed volatility driven by increasing interest rates, an economic downturn, ongoing geopolitical uncertainties, regulatory changes under the Inflation Reduction Act, and persistent supply chain disruptions, biotech manufacturers are steadily regaining stability.
With this in mind, it could be wise to monitor notable biotech stocks: Moderna, Inc. (MRNA), MacroGenics, Inc. (MGNX), and Amicus Therapeutics, Inc. (FOLD). Before we delve into the highlighted stocks, let's explore the current landscape in the biotech industry.
